Classification of diseases and injuries



Download 7.04 Mb.
Page7/46
Date conversion08.07.2018
Size7.04 Mb.
1   2   3   4   5   6   7   8   9   10   ...   46

CARCINOMA IN SITU (230-234)

Includes: Bowen's disease

erythroplasia

Queyrat's erythroplasia

Excludes: leukoplakia - see Alphabetic Index

230 Carcinoma in situ of digestive organs

230.0 Lip, oral cavity, and pharynx

Gingiva


Hypopharynx

Mouth [any part]

Nasopharynx

Oropharynx

Salivary gland or duct

Tongue


Excludes: aryepiglottic fold or interarytenoid fold, laryngeal aspect (231.0)

epiglottis:

NOS (231.0)

suprahyoid portion (231.0)

skin of lip (232.0)

230.1 Esophagus

230.2 Stomach

Body of stomach

Cardia of stomach

Fundus of stomach

Cardiac orifice

Pylorus


230.3 Colon

Appendix


Cecum

Ileocecal valve

Large intestine NOS

Excludes: rectosigmoid junction (230.4)

230.4 Rectum

Rectosigmoid junction

230.5 Anal canal

Anal sphincter

230.6 Anus, unspecified

Excludes: anus:

margin (232.5)

skin (232.5)

perianal skin (232.5)

230.7 Other and unspecified parts of intestine

Duodenum

Ileum


Jejunum

Small intestine NOS

Excludes: ampulla of Vater (230.8)

230.8 Liver and biliary system

Ampulla of Vater

Common bile duct

Cystic duct

Gallbladder

Hepatic duct

Sphincter of Oddi

230.9 Other and unspecified digestive organs

Digestive organ NOS

Gastrointestinal tract NOS

Pancreas


Spleen

231 Carcinoma in situ of respiratory system

231.0 Larynx

Cartilage:

arytenoid

cricoid


cuneiform

thyroid


Epiglottis:

NOS


posterior surface

suprahyoid portion

Vocal cords (false) (true)

Excludes: aryepiglottic fold or interarytenoid fold:

NOS (230.0)

hypopharyngeal aspect (230.0)

marginal zone (230.0)

231.1 Trachea

231.2 Bronchus and lung

Carina


Hilus of lung

231.8 Other specified parts of respiratory system

Accessory sinuses

Middle ear

Nasal cavities

Pleura


Excludes: ear (external) (skin) (232.2)

nose NOS (234.8)

skin (232.3)

231.9 Respiratory system, part unspecified

Respiratory organ NOS

232 Carcinoma in situ of skin

Includes: pigment cells

Excludes: melanoma in situ of skin (172.0-172.9)

232.0 Skin of lip

Excludes: vermilion border of lip (230.0)

232.1 Eyelid, including canthus

232.2 Ear and external auditory canal

232.3 Skin of other and unspecified parts of face

232.4 Scalp and skin of neck

232.5 Skin of trunk, except scrotum

Anus, margin

Axillary fold

Perianal skin

Skin of:

abdominal wall

anus

back


breast

buttock


chest wall

groin


perineum

Umbilicus

Excludes: anal canal (230.5)

anus NOS (230.6)

skin of genital organs (233.30-233.39, 233.5-233.6)

232.6 Skin of upper limb, including shoulder

232.7 Skin of lower limb, including hip

232.8 Other specified sites of skin

232.9 Skin, site unspecified

233 Carcinoma in situ of breast and genitourinary system

233.0 Breast

Excludes: Paget's disease (174.0-174.9)

skin of breast (232.5)

233.1 Cervix uteri

Adenocarcinoma in situ of cervix

Cervical intraepithelial glandular neoplasia, grade III

Cervical intraepithelial neoplasia III [CIN III]

Severe dysplasia of cervix

Excludes: cervical intraepithelial neoplasia II [CIN II] (622.12)

cytologic evidence of malignancy without histologic confirmation (795.06)

high grade squamous intraepithelial lesion (HGSIL) (795.04)

moderate dysplasia of cervix (622.12)

233.2 Other and unspecified parts of uterus

233.3 Other and unspecified female genital organs

233.30 Unspecified female genital organ

233.31 Vagina

Severe dysplasia of vagina

Vaginal intraepithelial neoplasia [VAIN III]

233.32 Vulva

Severe dysplasia of vulva

Vulvar intraepithelial neoplasia [VIN III]

233.39 Other female genital organ

233.4 Prostate

233.5 Penis

233.6 Other and unspecified male genital organs

233.7 Bladder

233.9 Other and unspecified urinary organs

234 Carcinoma in situ of other and unspecified sites

234.0 Eye

Excludes: cartilage of eyelid (234.8)

eyelid (skin) (232.1)

optic nerve (234.8)

orbital bone (234.8)

234.8 Other specified sites

Endocrine gland [any]

234.9 Site unspecified

Carcinoma in situ NOS

NEOPLASMS OF UNCERTAIN BEHAVIOR (235-238)

Note: Categories 235-238 classify by site certain histo-morphologically well-defined neoplasms, the subsequent behavior of which cannot be predicted from the present appearance.

235 Neoplasm of uncertain behavior of digestive and respiratory systems

Excludes: stromal tumors of uncertain behavior of digestive system (238.1)

235.0 Major salivary glands

Gland:

parotid


sublingual

submandibular

Excludes: minor salivary glands (235.1)

235.1 Lip, oral cavity, and pharynx

Gingiva

Hypopharynx



Minor salivary glands

Mouth


Nasopharynx

Oropharynx

Tongue

Excludes: aryepiglottic fold or interarytenoid fold, laryngeal aspect (235.6)



epiglottis:

NOS (235.6)

suprahyoid portion (235.6)

skin of lip (238.2)

235.2 Stomach, intestines, and rectum

235.3 Liver and biliary passages

Ampulla of Vater

Bile ducts [any]

Gallbladder

Liver


235.4 Retroperitoneum and peritoneum

235.5 Other and unspecified digestive organs

Anal:

canal


sphincter

Anus NOS


Esophagus

Pancreas


Spleen

Excludes: anus:

margin (238.2)

skin (238.2)

perianal skin (238.2)

235.6 Larynx

Excludes: aryepiglottic fold or interarytenoid fold:

NOS (235.1)

hypopharyngeal aspect (235.1)

marginal zone (235.1)

235.7 Trachea, bronchus, and lung

235.8 Pleura, thymus, and mediastinum

235.9 Other and unspecified respiratory organs

Accessory sinuses

Middle ear

Nasal cavities

Respiratory organ NOS

Excludes: ear (external) (skin) (238.2)

nose (238.8)

skin (238.2)

236 Neoplasm of uncertain behavior of genitourinary organs

236.0 Uterus

236.1 Placenta

Chorioadenoma (destruens)

Invasive mole

Malignant hydatid mole

Malignant hydatidiform mole

236.2 Ovary

Use additional code to identify any functional activity

236.3 Other and unspecified female genital organs

236.4 Testis

Use additional code to identify any functional activity

236.5 Prostate

236.6 Other and unspecified male genital organs

236.7 Bladder

236.9 Other and unspecified urinary organs

236.90 Urinary organ, unspecified

236.91 Kidney and ureter

236.99 Other

237 Neoplasm of uncertain behavior of endocrine glands and nervous system

237.0 Pituitary gland and craniopharyngeal duct

Use additional code to identify any functional activity

237.1 Pineal gland

237.2 Adrenal gland

Suprarenal gland

Use additional code to identify any functional activity

237.3 Paraganglia

Aortic body

Carotid body

Coccygeal body

Glomus jugulare

237.4 Other and unspecified endocrine glands

Parathyroid gland

Thyroid gland

237.5 Brain and spinal cord

237.6 Meninges

Meninges:

NOS


cerebral

spinal


237.7 Neurofibromatosis

237.70 Neurofibromatosis, unspecified

237.71 Neurofibromatosis, type 1 [von Recklinghausen's disease]

237.72 Neurofibromatosis, type 2 [acoustic neurofibromatosis]

237.73 Schwannomatosis

237.79 Other neurofibromatosis

237.9 Other and unspecified parts of nervous system

Cranial nerves

Excludes: peripheral, sympathetic, and parasympathetic nerves and ganglia (238.1)

238 Neoplasm of uncertain behavior of other and unspecified sites and tissues

238.0 Bone and articular cartilage

Excludes: cartilage:

ear (238.1)

eyelid (238.1)

larynx (235.6)

nose (235.9)

synovia (238.1)

238.1 Connective and other soft tissue

Peripheral, sympathetic, and parasympathetic nerves and ganglia

Stromal tumors of digestive system

Excludes: cartilage (of):

articular (238.0)

larynx (235.6)

nose (235.9)

connective tissue of breast (238.3)

238.2 Skin

Excludes: anus NOS (235.5)

skin of genital organs (236.3, 236.6)

vermilion border of lip (235.1)

238.3 Breast

Excludes: skin of breast (238.2)

238.4 Polycythemia vera

238.5 Histiocytic and mast cells

Mast cell tumor NOS

Mastocytoma NOS

238.6 Plasma cells

Plasmacytoma NOS

Solitary myeloma

238.7 Other lymphatic and hematopoietic tissues

Excludes: acute myelogenous leukemia (205.0)

chronic myelomonocytic leukemia (205.1)

myelosclerosis NOS (289.89)

myelosis:

NOS (205.9)

megakaryocytic (207.2)

238.71 Essential thrombocythemia

Essential hemorrhagic thrombocythemia

Essential thrombocytosis

Idiopathic (hemorrhagic) thrombocythemia

Primary thrombocytosis

238.72 Low grade myelodysplastic syndrome lesions

Refractory anemia (RA)

Refractory anemia with excess blasts-1 (RAEB-1)

Refractory anemia with ringed sideroblasts (RARS)

Refractory cytopenia with multilineage dysplasia (RCMD)

Refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS)

238.73 High grade myelodysplastic syndrome lesions

Refractory anemia with excess blasts-2 (RAEB-2)

238.74 Myelodysplastic syndrome with 5q deletion

5q minus syndrome NOS

Excludes: constitutional 5q deletion (758.39)

high grade myelodysplastic syndrome with 5q deletion (238.73)

238.75 Myelodysplastic syndrome, unspecified

238.76 Myelofibrosis with myeloid metaplasia

Agnogenic myeloid metaplasia

Idiopathic myelofibrosis (chronic)

Myelosclerosis with myeloid metaplasia

Primary myelofibrosis

Excludes: myelofibrosis NOS (289.83)

myelophthisic anemia (284.2)

myelophthisis (284.2)

secondary myelofibrosis (289.83)

238.77 Post-transplant lymphoproliferative disorder (PTLD)

Code first complications of transplant (996.80-996.89)

238.79 Other lymphatic and hematopoietic tissues

Lymphoproliferative disease (chronic) NOS

Megakaryocytic myelosclerosis

Myeloproliferative disease (chronic) NOS

Panmyelosis (acute)

238.8 Other specified sites

Eye

Heart


Excludes: eyelid (skin) (238.2)

cartilage (238.1)

238.9 Site unspecified

NEOPLASMS OF UNSPECIFIED NATURE (239)

239 Neoplasms of unspecified nature

Note: Category 239 classifies by site neoplasms of unspecified morphology and behavior. The term "mass," unless otherwise stated, is not to be regarded as a neoplastic growth.

Includes: "growth" NOS

neoplasm NOS

new growth NOS

tumor NOS

239.0 Digestive system

Excludes: anus:

margin (239.2)

skin (239.2)

perianal skin (239.2)

239.1 Respiratory system

239.2 Bone, soft tissue, and skin

Excludes: anal canal (239.0)

anus NOS (239.0)

bone marrow (202.9)

cartilage:

larynx (239.1)

nose (239.1)

connective tissue of breast (239.3)

skin of genital organs (239.5)

vermilion border of lip (239.0)

239.3 Breast

Excludes: skin of breast (239.2)

239.4 Bladder

239.5 Other genitourinary organs

239.6 Brain

Excludes: cerebral meninges (239.7)

cranial nerves (239.7)

239.7 Endocrine glands and other parts of nervous system

Excludes: peripheral, sympathetic, and parasympathetic nerves and ganglia (239.2)

239.8 Other specified sites

Excludes: eyelid (skin) (239.2)

cartilage (239.2)

great vessels (239.2)

optic nerve (239.7)

239.81 Retina and choroid

Dark area on retina

Retinal freckle

239.89 Other specified sites

239.9 Site unspecified



3. ENDOCRINE, NUTRITIONAL AND METABOLIC DISEASES, AND IMMUNITY DISORDERS (240-279)

Excludes: endocrine and metabolic disturbances specific

to the fetus and newborn (775.0-775.9)

Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Codes in Chapter 3 (i.e., 242.8, 246.0, 251-253, 255-259) may be used to identify such functional activity associated with any neoplasm, or by ectopic endocrine tissue.

DISORDERS OF THYROID GLAND (240-246)

240 Simple and unspecified goiter

240.0 Goiter, specified as simple

Any condition classifiable to 240.9, specified as simple

240.9 Goiter, unspecified

Enlargement of thyroid

Goiter or struma:

NOS


diffuse colloid

endemic


hyperplastic

nontoxic (diffuse)

parenchymatous

sporadic


Excludes: congenital (dyshormonogenic) goiter (246.1)

241 Nontoxic nodular goiter

Excludes: adenoma of thyroid (226)

cystadenoma of thyroid (226)

241.0 Nontoxic uninodular goiter

Thyroid nodule

Uninodular goiter (nontoxic)

241.1 Nontoxic multinodular goiter

Multinodular goiter (nontoxic)

241.9 Unspecified nontoxic nodular goiter

Adenomatous goiter

Nodular goiter (nontoxic) NOS

Struma nodosa (simplex)

242 Thyrotoxicosis with or without goiter

Excludes: neonatal thyrotoxicosis (775.3)

The following fifth-digit subclassification is for use with category 242:

0 without mention of thyrotoxic crisis or storm

1 with mention of thyrotoxic crisis or storm

242.0 Toxic diffuse goiter

[0-1]


Basedow's disease

Exophthalmic or toxic goiter NOS

Graves' disease

Primary thyroid hyperplasia

242.1 Toxic uninodular goiter

[0-1]


Thyroid nodule, toxic or with hyperthyroidism

Uninodular goiter, toxic or with hyperthyroidism

242.2 Toxic multinodular goiter

[0-1]


Secondary thyroid hyperplasia

242.3 Toxic nodular goiter, unspecified

[0-1]

Adenomatous goiter, toxic or with hyperthyroidism



Nodular goiter, toxic or with hyperthyroidism

Struma nodosa, toxic or with hyperthyroidism

Any condition classifiable to 241.9 specified as toxic or with hyperthyroidism

242.4 Thyrotoxicosis from ectopic thyroid nodule

[0-1]

242.8 Thyrotoxicosis of other specified origin



[0-1]

Overproduction of thyroid-stimulating hormone [TSH]

Thyrotoxicosis:

factitia from ingestion of excessive thyroid material

Use additional E code to identify cause, if drug-induced

242.9 Thyrotoxicosis without mention of goiter or other cause

[0-1]

Hyperthyroidism NOS



Thyrotoxicosis NOS

243 Congenital hypothyroidism

Congenital thyroid insufficiency

Cretinism (athyrotic) (endemic)

Use additional code to identify associated intellectual disabilities

Excludes: congenital (dyshormonogenic) goiter (246.1)

244 Acquired hypothyroidism

Includes: athyroidism (acquired)

hypothyroidism (acquired)

myxedema (adult) (juvenile)

thyroid (gland) insufficiency (acquired)

244.0 Postsurgical hypothyroidism

244.1 Other postablative hypothyroidism

Hypothyroidism following therapy, such as irradiation

244.2 Iodine hypothyroidism

Hypothyroidism resulting from administration or ingestion of iodide

Use additional E to identify drug

Excludes: hypothyroidism resulting from administration of radioactive iodine (244.1)

244.3 Other iatrogenic hypothyroidism

Hypothyroidism resulting from:

P-aminosalicylic acid [PAS]

Phenylbutazone

Resorcinol

Iatrogenic hypothyroidism NOS

Use additional E to identify drug

244.8 Other specified acquired hypothyroidism

Secondary hypothyroidism NEC

244.9 Unspecified hypothyroidism

Hypothyroidism, primary or NOS

Myxedema, primary or NOS

245 Thyroiditis

245.0 Acute thyroiditis

Abscess of thyroid

Thyroiditis:

nonsuppurative, acute

pyogenic


suppurative

Use additional code to identify organism

245.1 Subacute thyroiditis

Thyroiditis:

de Quervain's

giant cell

granulomatous

viral


245.2 Chronic lymphocytic thyroiditis

Hashimoto's disease

Struma lymphomatosa

Thyroiditis:

autoimmune

lymphocytic (chronic)

245.3 Chronic fibrous thyroiditis

Struma fibrosa

Thyroiditis:

invasive (fibrous)

ligneous

Riedel's


245.4 Iatrogenic thyroiditis

Use additional E to identify cause

245.8 Other and unspecified chronic thyroiditis

Chronic thyroiditis:

NOS

nonspecific



245.9 Thyroiditis, unspecified

Thyroiditis NOS

246 Other disorders of thyroid

246.0 Disorders of thyrocalcitonin secretion

Hypersecretion of calcitonin or thyrocalcitonin

246.1 Dyshormonogenic goiter

Congenital (dyshormonogenic) goiter

Goiter due to enzyme defect in synthesis of thyroid hormone

Goitrous cretinism (sporadic)

246.2 Cyst of thyroid

Excludes: cystadenoma of thyroid (226)

246.3 Hemorrhage and infarction of thyroid

246.8 Other specified disorders of thyroid

Abnormality of thyroid-binding globulin

Atrophy of thyroid

Hyper-TBG-nemia

Hypo-TBG-nemia

246.9 Unspecified disorder of thyroid



DISEASES OF OTHER ENDOCRINE GLANDS (249-259)

249 Secondary diabetes mellitus

Includes: diabetes mellitus (due to) (in) (secondary) (with):

drug-induced or chemical induced

infection

Excludes: gestational diabetes (648.8)

hyperglycemia NOS (790.29)

neonatal diabetes mellitus (775.1)

nonclinical diabetes (790.29)

Type I diabetes - see category 250

Type II diabetes - see category 250

The following fifth-digit subclassification is for use with category 249:

0 not stated as uncontrolled

1 uncontrolled

Use additional code to identify any associated insulin use (V58.67)

249.0 Secondary diabetes mellitus without mention of complication

[0-1]

Secondary diabetes mellitus without mention of complication or manifestation classifiable to 249.1-249.9



Secondary diabetes mellitus NOS

249.1 Secondary diabetes mellitus with ketoacidosis

[0-1]

Secondary diabetes mellitus with diabetic acidosis without mention of coma



Secondary diabetes mellitus with diabetic ketosis without mention of coma

249.2 Secondary diabetes mellitus with hyperosmolarity

[0-1]

Secondary diabetes mellitus with hyperosmolar (nonketotic) coma



249.3 Secondary diabetes mellitus with other coma

[0-1]


Secondary diabetes mellitus with diabetic coma (with ketoacidosis)

Secondary diabetes mellitus with diabetic hypoglycemic coma

Secondary diabetes mellitus with insulin coma NOS

Excludes: secondary diabetes mellitus with hyperosmolar coma (249.2)

249.4 Secondary diabetes mellitus with renal manifestations

[0-1]


Use additional code to identify manifestation, as:

chronic kidney disease (585.1-585.9)

diabetic nephropathy NOS (583.81)

diabetic nephrosis (581.81)

intercapillary glomerulosclerosis (581.81)

Kimmelstiel-Wilson syndrome (581.81)

249.5 Secondary diabetes mellitus with ophthalmic manifestations

[0-1]


Use additional code: to identify manifestation, as:

diabetic blindness (369.00-369.9)

diabetic cataract (366.41)

diabetic glaucoma (365.44)

diabetic macular edema (362.07)

diabetic retinal edema (362.07)

diabetic retinopathy (362.01-362.07)

249.6 Secondary diabetes mellitus with neurological manifestations

[0-1]

Use additional code to identify manifestation, as:



diabetic amyotrophy (353.5)

diabetic gastroparalysis (536.3)

diabetic gastroparesis (536.3)

diabetic mononeuropathy (354.0-355.9)

diabetic neurogenic arthropathy (713.5)

diabetic peripheral autonomic neuropathy (337.1)

diabetic polyneuropathy (357.2)

249.7 Secondary diabetes mellitus with peripheral circulatory disorders

[0-1]

Use additional code to identify manifestation, as:



diabetic gangrene (785.4)

diabetic peripheral angiopathy (443.81)

249.8 Secondary diabetes mellitus with other specified manifestations

[0-1]


Secondary diabetic hypoglycemia in diabetes mellitus

Secondary hypoglycemic shock in diabetes mellitus

Use additional code to identify manifestation, as:

any associated ulceration (707.10-707.19, 707.8, 707.9)

diabetic bone changes (731.8)

249.9 Secondary diabetes mellitus with unspecified complication

[0-1]

250 Diabetes mellitus



Excludes: gestational diabetes (648.8)

hyperglycemia NOS (790.29)

neonatal diabetes mellitus (775.1)

nonclinical diabetes (790.29)

secondary diabetes (249.0-249.9)

The following fifth-digit subclassification is for use with category 250:

0 type II or unspecified type, not stated as uncontrolled

Fifth-digit 0 is for use for type II patients, even if the patient requires insulin

Use additional code, if applicable, for associated long-term (current) insulin use V58.67

1 type I [juvenile type], not stated as uncontrolled

2 type II or unspecified type, uncontrolled

Use additional code, if applicable, for associated long-term (current) insulin use V58.67

Fifth-digit 2 is for use for type II, adult-onset, diabetic patients, even if the patient requires insulin

3 type I [juvenile type], uncontrolled

250.0 Diabetes mellitus without mention of complication

[0-3]


Diabetes mellitus without mention of complication or manifestation classifiable to 250.1-250.9

Diabetes (mellitus) NOS

250.1 Diabetes with ketoacidosis

[0-3]


Diabetic:

acidosis without mention of coma

ketosis without mention of coma

250.2 Diabetes with hyperosmolarity

[0-3]

Hyperosmolar (nonketotic) coma



250.3 Diabetes with other coma

[0-3]


Diabetic coma (with ketoacidosis)

Diabetic hypoglycemic coma

Insulin coma NOS

Excludes: diabetes with hyperosmolar coma (250.2)

250.4 Diabetes with renal manifestations

[0-3]


Use additional code to identify manifestation, as:

chronic kidney disease (585.1-585.9)

diabetic:

nephropathy NOS (583.81)

nephrosis (581.81)

intercapillary glomerulosclerosis (581.81)

Kimmelstiel-Wilson syndrome (581.81)

250.5 Diabetes with ophthalmic manifestations

[0-3]

Use additional code to identify manifestation, as:



diabetic:

blindness (369.00-369.9)

cataract (366.41)

glaucoma (365.44)

macular edema (362.07)

retinal edema (362.07)

retinopathy (362.01-362.07)

250.6 Diabetes with neurological manifestations

[0-3]

Use additional code to identify manifestation, as:



diabetic:

amyotrophy (353.5)

gastroparalysis (536.3)

gastroparesis (536.3)

mononeuropathy (354.0-355.9)

neurogenic arthropathy (713.5)

peripheral autonomic neuropathy (337.1)

polyneuropathy (357.2)

250.7 Diabetes with peripheral circulatory disorders

[0-3]


Use additional code to identify manifestation, as:

diabetic:

gangrene (785.4)

peripheral angiopathy (443.81)

250.8 Diabetes with other specified manifestations

[0-3]


Diabetic hypoglycemia NOS

Hypoglycemic shock NOS

Use additional code to identify manifestation, as:

any associated ulceration (707.10-707.19, 707.8, 707.9)

diabetic bone changes (731.8)

250.9 Diabetes with unspecified complication

[0-3]

251 Other disorders of pancreatic internal secretion



251.0 Hypoglycemic coma

Iatrogenic hyperinsulinism

Non-diabetic insulin coma

Use additional E code to identify cause, if drug-induced

Excludes: hypoglycemic coma in diabetes mellitus (249.3, 250.3)

251.1 Other specified hypoglycemia

Hyperinsulinism:

NOS


ectopic

functional

Hyperplasia of pancreatic islet beta cells NOS

Excludes: hypoglycemia in diabetes mellitus (249.8, 250.8)

hypoglycemia in infant of diabetic mother (775.0)

hypoglycemic coma (251.0)

neonatal hypoglycemia (775.6)

Use additional E code to identify cause, if drug-induced

251.2 Hypoglycemia, unspecified

Hypoglycemia:

NOS

reactive


spontaneous

Excludes: hypoglycemia:

with coma (251.0)

in diabetes mellitus (249.8, 250.8)

leucine-induced (270.3)

251.3 Postsurgical hypoinsulinemia

Hypoinsulinemia following complete or partial pancreatectomy

Postpancreatectomy hyperglycemia

Use additional code to identify (any associated):

acquired absence of pancreas (V88.11-V88.12)

insulin use (V58.67)

secondary diabetes mellitus (249.00-249.91)

Excludes: transient hyperglycemia post procedure (790.29)

transient hypoglycemia post procedure (251.2)

251.4 Abnormality of secretion of glucagon

Hyperplasia of pancreatic islet alpha cells with glucagon excess

251.5 Abnormality of secretion of gastrin

Hyperplasia of pancreatic alpha cells with gastrin excess

Zollinger-Ellison syndrome

251.8 Other specified disorders of pancreatic internal secretion

251.9 Unspecified disorder of pancreatic internal secretion

Islet cell hyperplasia NOS

252 Disorders of parathyroid gland

Excludes: hungry bone syndrome (275.5)

252.0 Hyperparathyroidism

Excludes: ectopic hyperparathyroidism (259.3)

252.00 Hyperparathyroidism, unspecified

252.01 Primary hyperparathyroidism

Hyperplasia of parathyroid

252.02 Secondary hyperparathyroidism, non-renal

Excludes: secondary hyperparathyroidism (of renal origin) (588.81)

252.08 Other hyperparathyroidism

Tertiary hyperparathyroidism

252.1 Hypoparathyroidism

Parathyroiditis (autoimmune)

Tetany:


parathyroid

parathyroprival

Excludes: pseudohypoparathyroidism (275.49)

pseudopseudohypoparathyroidism (275.49)

tetany NOS (781.7)

transitory neonatal hypoparathyroidism (775.4)

252.8 Other specified disorders of parathyroid gland

Cyst of parathyroid gland

Hemorrhage of parathyroid gland

252.9 Unspecified disorder of parathyroid gland

253 Disorders of the pituitary gland and its hypothalamic control

Includes: the listed conditions whether the disorder is in the pituitary or the hypothalamus

Excludes: Cushing's syndrome (255.0)

253.0 Acromegaly and gigantism

Overproduction of growth hormone

253.1 Other and unspecified anterior pituitary hyperfunction

Forbes-Albright syndrome

Excludes: overproduction of:

ACTH (255.3)

thyroid-stimulating hormone [TSH] (242.8)

253.2 Panhypopituitarism

Cachexia, pituitary

Necrosis of pituitary (postpartum)

Pituitary insufficiency NOS

Sheehan's syndrome

Simmonds' disease

Excludes: iatrogenic hypopituitarism (253.7)

253.3 Pituitary dwarfism

Isolated deficiency of (human) growth hormone [HGH]

Lorain-Levi dwarfism

253.4 Other anterior pituitary disorders

Isolated or partial deficiency of an anterior pituitary hormone, other than growth hormone

Prolactin deficiency

253.5 Diabetes insipidus

Vasopressin deficiency

Excludes: nephrogenic diabetes insipidus (588.1)

253.6 Other disorders of neurohypophysis

Syndrome of inappropriate secretion of antidiuretic hormone [ADH]

Excludes: ectopic antidiuretic hormone secretion (259.3)

253.7 Iatrogenic pituitary disorders

Hypopituitarism:

hormone-induced

hypophysectomy-induced

postablative

radiotherapy-induced

Use additional E code to identify cause

253.8 Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin

Abscess of pituitary

Adiposogenital dystrophy

Cyst of Rathke's pouch

Fröhlich's syndrome

Excludes: craniopharyngioma (237.0)

253.9 Unspecified

Dyspituitarism

254 Diseases of thymus gland

Excludes: aplasia or dysplasia with immunodeficiency (279.2)

hypoplasia with immunodeficiency (279.2)

myasthenia gravis (358.00-358.01)

254.0 Persistent hyperplasia of thymus

Hypertrophy of thymus

254.1 Abscess of thymus

254.8 Other specified diseases of thymus gland

Atrophy of thymus

Cyst of thymus

Excludes: thymoma (212.6)

254.9 Unspecified disease of thymus gland

255 Disorders of adrenal glands

Includes: the listed conditions whether the basic disorder is in the adrenals or is pituitary-induced

255.0 Cushing's syndrome

Adrenal hyperplasia due to excess ACTH

Cushing's syndrome:

NOS


iatrogenic

idiopathic

pituitary-dependent

Ectopic ACTH syndrome

Iatrogenic syndrome of excess cortisol

Overproduction of cortisol

Use additional E code to identify cause, if drug-induced

Excludes: congenital adrenal hyperplasia (255.2)

255.1 Hyperaldosteronism

255.10 Hyperaldosteronism, unspecified

Aldosteronism NOS

Primary aldosteronism, unspecified

Excludes: Conn's syndrome (255.12)

255.11 Glucocorticoid-remediable aldosteronism

Familial aldosteronism type I

Excludes: Conn's syndrome (255.12)

255.12 Conn's syndrome

255.13 Bartter's syndrome

255.14 Other secondary aldosteronism

255.2 Adrenogenital disorders

Adrenogenital syndromes, virilizing or feminizing, whether acquired or associated with congenital adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis

Achard-Thiers syndrome

Congenital adrenal hyperplasia

Female adrenal pseudohermaphroditism

Male:

macrogenitosomia praecox



sexual precocity with adrenal hyperplasia

Virilization (female) (suprarenal)

Excludes: adrenal hyperplasia due to excess ACTH (255.0)

isosexual virilization (256.4)

255.3 Other corticoadrenal overactivity

Acquired benign adrenal androgenic overactivity

Overproduction of ACTH

255.4 Corticoadrenal insufficiency

Excludes: tuberculous Addison's disease (017.6)

255.41 Glucocorticoid deficiency

Addisonian crisis

Addison's disease NOS

Adrenal atrophy (autoimmune)

Adrenal calcification

Adrenal crisis

Adrenal hemorrhage

Adrenal infarction

Adrenal insufficiency NOS

Combined glucocorticoid and mineralocorticoid deficiency

Corticoadrenal insufficiency NOS

255.42 Mineralocorticoid deficiency

Hypoaldosteronism

Excludes: combined glucocorticoid and mineralocorticoid deficiency (255.41)

255.5 Other adrenal hypofunction

Adrenal medullary insufficiency

Excludes: Waterhouse-Friderichsen syndrome (meningococcal) (036.3)

255.6 Medulloadrenal hyperfunction

Catecholamine secretion by pheochromocytoma

255.8 Other specified disorders of adrenal glands

Abnormality of cortisol-binding globulin

255.9 Unspecified disorder of adrenal glands

256 Ovarian dysfunction

256.0 Hyperestrogenism

256.1 Other ovarian hyperfunction

Hypersecretion of ovarian androgens

256.2 Postablative ovarian failure

Ovarian failure:

iatrogenic

postirradiation

postsurgical

Use additional code for states associated with artificial menopause (627.4)

Excludes:: acquired absence of ovary (V45.77)

asymptomatic age-related (natural) postmenopausal status (V49.81)

256.3 Other ovarian failure

Use additional code for states associated with natural menopause (627.2)

Excludes:: asymptomatic age-related (natural) postmenopausal status (V49.81)

256.31 Premature menopause

256.39 Other ovarian failure

Delayed menarche

Ovarian hypofunction

Primary ovarian failure NOS

256.4 Polycystic ovaries

Isosexual virilization Stein-Leventhal syndrome

256.8 Other ovarian dysfunction

256.9 Unspecified ovarian dysfunction

257 Testicular dysfunction

257.0 Testicular hyperfunction

Hypersecretion of testicular hormones

257.1 Postablative testicular hypofunction

Testicular hypofunction:

iatrogenic

postirradiation

postsurgical

257.2 Other testicular hypofunction

Defective biosynthesis of testicular androgen

Eunuchoidism:

NOS

hypogonadotropic



Failure:

Leydig's cell, adult

seminiferous tubule, adult

Testicular hypogonadism

Excludes: azoospermia (606.0)

257.8 Other testicular dysfunction

Excludes: androgen insensitivity syndrome (259.50-259.52)

257.9 Unspecified testicular dysfunction

258 Polyglandular dysfunction and related disorders

258.0 Polyglandular activity in multiple endocrine adenomatosis

Multiple endocrine neoplasia [MEN] syndromes

Use additional codes to identify any malignancies and other conditions associated with the syndromes

258.01 Multiple endocrine neoplasia [MEN] type I

Wermer's syndrome

258.02 Multiple endocrine neoplasia [MEN] type IIA

Sipple's syndrome

258.03 Multiple endocrine neoplasia [MEN] type IIB

258.1 Other combinations of endocrine dysfunction

Lloyd's syndrome

Schmidt's syndrome

258.8 Other specified polyglandular dysfunction

258.9 Polyglandular dysfunction, unspecified

259 Other endocrine disorders

259.0 Delay in sexual development and puberty, not elsewhere classified

Delayed puberty

259.1 Precocious sexual development and puberty, not elsewhere classified

Sexual precocity:

NOS


constitutional

cryptogenic

idiopathic

259.2 Carcinoid syndrome

Hormone secretion by carcinoid tumors

259.3 Ectopic hormone secretion, not elsewhere classified

Ectopic:

antidiuretic hormone secretion [ADH]

hyperparathyroidism

Excludes: ectopic ACTH syndrome (255.0)

259.4 Dwarfism, not elsewhere classified

Dwarfism:

NOS

constitutional



Excludes: dwarfism:

achondroplastic (756.4)

intrauterine (759.7)

nutritional (263.2)

pituitary (253.3)

renal (588.0)

progeria (259.8)

259.5 Androgen insensitivity syndrome

259.50 Androgen insensitivity, unspecified

259.51 Androgen insensitivity syndrome

Complete androgen insensitivity

de Quervain's syndrome

Goldberg-Maxwell Syndrome

259.52 Partial androgen insensitivity

Partial androgen insensitivity

Reifenstein syndrome

259.8 Other specified endocrine disorders

Pineal gland dysfunction

Progeria

Werner's syndrome

259.9 Unspecified endocrine disorder

Disturbance:

endocrine NOS

hormone NOS

Infantilism NOS

1   2   3   4   5   6   7   8   9   10   ...   46


The database is protected by copyright ©dentisty.org 2016
send message

    Main page